Literature DB >> 31752570

Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis.

Miao Yang1, Yongming Du2, Yichao Hu3.   

Abstract

OBJECTIVE: This study aimed to evaluate the safety profile and feasibility of complete salpingectomy during cesarean delivery in women desiring permanent sterilization. DATA SOURCES: We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials from inception to July 2018. Study Selection: studies comparing total salpingectomy with tubal ligation during cesarean deliveries were included.
RESULTS: Nine studies involving a total of 1274 participants were eligible. Our analyses showed that the total operative time was slightly longer for the bilateral salpingectomy than for the tubal ligation group (MD = 5.81, 95% CI: 0.85-10.77). Two comparison groups were comparable with regard to intraoperative complications (RR = 1.42, 95% CI: 0.65-3.11), postoperative complications (RR = 1.70, 95% CI: 0.83-3.48), estimated blood loss in total procedures, need for blood transfusion, operative complications, risk of postpartum hemorrhage, surgical site infection, ICU admission, need for presentation to hospital, short-term ovarian reserve, and completion rate of sterilization surgeries (RR = 0.90, 95% CI: 0.80-1.00).
CONCLUSION: Complete salpingectomy slightly prolonged surgical time by a reasonable range and showed similar safety profile and greater cost-effectiveness than tubal ligation as permanent sterilization procedures at cesarean delivery.

Entities:  

Keywords:  Cesarean section; meta-analysis; salpingectomy; sterilization; tubal ligation

Mesh:

Year:  2019        PMID: 31752570     DOI: 10.1080/14767058.2019.1690446

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Patients' perceptions toward and the driving factors of decision-making for opportunistic bilateral salpingectomy at the time of cesarean section.

Authors:  Murat Yassa; Çiğdem Pulatoğlu
Journal:  Turk J Obstet Gynecol       Date:  2020-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.